» Articles » PMID: 27858964

Evidence for Clinical Progression of Unipolar and Bipolar Disorders

Overview
Specialty Psychiatry
Date 2016 Nov 19
PMID 27858964
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: It is a widely held belief that affective disorders are progressive of nature; however, some recent reviews have questioned this belief. The objective of the present systematic literature review was to present evidence for associations between number of affective episodes and (i) the risk of recurrence of episodes, (ii) probability of recovery from episodes, (iii) severity of episodes, (iv) the threshold for developing episodes, and (v) progression of cognitive deficits in unipolar and bipolar disorders.

Method: A systematic review comprising an extensive literature search conducted in Medline, Embase, and PsychInfo up to September 2016 and including cross-references from identified papers and reviews.

Results: Most of the five areas are superficially investigated and hampered by methodological challenges. Nevertheless, studies with the longest follow-up periods, using survival analysis methods, taking account of the individual heterogeneity all support a clinical progressive course of illness. Overall, increasing number of affective episodes seems to be associated with (i) increasing risk of recurrence, (ii) increasing duration of episodes, (iii) increasing symptomatic severity of episodes, (iv) decreasing threshold for developing episodes, and (v) increasing risk of developing dementia.

Conclusion: Although the course of illness is heterogeneous, there is evidence for clinical progression of unipolar and bipolar disorders.

Citing Articles

Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives.

Stanislaus S, Coello K, Kjaerstad H, Sletved K, Miskowiak K, Faurholt-Jepsen M Int J Bipolar Disord. 2025; 13(1):10.

PMID: 40080331 PMC: 11906955. DOI: 10.1186/s40345-025-00377-8.


RNA editing-based biomarker blood test for the diagnosis of bipolar disorder: protocol of the EDIT-B study.

Miranda-Mendizabal A, Vetter D, Zambrano J, Zarp J, Chavarria V, Gimenez-Palomo A Ann Gen Psychiatry. 2025; 24(1):7.

PMID: 39915772 PMC: 11803998. DOI: 10.1186/s12991-024-00544-8.


The links between neuroinflammation, brain structure and depressive disorder: A cross-sectional study protocol.

Milasauskiene E, Burkauskas J, Jesmanas S, Gleizniene R, Borutaite V, Skemiene K PLoS One. 2024; 19(11):e0311218.

PMID: 39565757 PMC: 11578540. DOI: 10.1371/journal.pone.0311218.


Effects of low-dose aspirin in bipolar disorder: study protocol for a randomised controlled trial (the A-Bipolar RCT).

Bruun C, Zarp J, Forman J, Coello K, Miskowiak K, Vinberg M BMJ Open. 2024; 14(11):e084105.

PMID: 39557557 PMC: 11575337. DOI: 10.1136/bmjopen-2024-084105.


How much risk does delirium represent for the development of dementia?: Retrospective cohort study from over 260,000 patients record in a solitary institution.

Minami H, Toyoda K, Hata T, Nishihara M, Neo M, Nishida K Front Psychiatry. 2024; 15:1387615.

PMID: 39345923 PMC: 11427876. DOI: 10.3389/fpsyt.2024.1387615.